Indeed, silencing of USP4 significantly led to reduced population of CD133+ cells, a marker for CSCs in NSCLC, concomitant with reduced tumorsphere formation (Figure 1C–E and Figure S3A–C). Here, USP4 is linked to non-small cell lung carcinoma.